Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Selling, General & Administrative (2010 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) posted Selling, General & Administrative of $9.75 million for Q2 2026, up 4.3% from $9.35 million a year earlier and up 5.6% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Lexicon Pharmaceuticals was $35.34 million, down 61.9% year-over-year; for FY2025, it was $37.32 million, down 73.9% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
  • In prior years, Lexicon Pharmaceuticals' Selling, General & Administrative was $143.1 million in FY2024 (+25.5%), $113.98 million in FY2023 (+137.1%), $48.08 million in FY2022 (+48.7%) and $32.34 million in FY2021 (-31.5%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative since Q1 2025.
  • On a year-over-year basis, Selling, General & Administrative increased in two of the last eight quarters, with an average decline of 36.0%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2023, with growth of 180.8%; the weakest was Q3 2025, with a decline of 80.8%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $9.23 million (Q1 2026), $8.76 million (Q4 2025) and $7.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 9.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.75 Mn
Mar 31, 2026 9.23 Mn
Dec 31, 2025 8.76 Mn
Sep 30, 2025 7.60 Mn
Jun 30, 2025 9.35 Mn
Mar 31, 2025 11.61 Mn
Dec 31, 2024 32.26 Mn
Sep 30, 2024 39.59 Mn
Jun 30, 2024 39.19 Mn
Mar 31, 2024 32.06 Mn
Dec 31, 2023 32.61 Mn
Sep 30, 2023 32.23 Mn
Jun 30, 2023 30.01 Mn
Mar 31, 2023 19.14 Mn
Dec 31, 2022 16.33 Mn
Sep 30, 2022 12.58 Mn
Jun 30, 2022 10.69 Mn
Mar 31, 2022 8.49 Mn
Dec 31, 2021 8.85 Mn
Sep 30, 2021 7.30 Mn
API Access

Lexicon Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LXRX&period=max&api_key=YOUR_API_KEY